113 related articles for article (PubMed ID: 11706441)
1. [Prognosis value of p53 gene and cellular proliferation factors in malignant supratentorial gliomas].
Gil-Salú JL; González-Darder JM; Barcia Albacar JA; Pesudo JV; Vera-Román JM; Lázaro R; Alós M
Neurocirugia (Astur); 2001; 12(2):125-32. PubMed ID: 11706441
[TBL] [Abstract][Full Text] [Related]
2. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters.
McKeever PE; Ross DA; Strawderman MS; Brunberg JA; Greenberg HS; Junck L
J Neuropathol Exp Neurol; 1997 Jul; 56(7):798-805. PubMed ID: 9210876
[TBL] [Abstract][Full Text] [Related]
4. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
[TBL] [Abstract][Full Text] [Related]
5. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
Heesters MA; Koudstaal J; Go KG; Molenaar WM
J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
7. Relationship between Ki-67 labeling index and survival in high-grade glioma patients treated after surgery with tamoxifen.
Mastronardi L; Guiducci A; Puzzilli F; Ruggeri A
J Neurosurg Sci; 1999 Dec; 43(4):263-70. PubMed ID: 10864388
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic factors in malignant gliomas].
Ushio Y; Kochi M
Gan To Kagaku Ryoho; 1996 Apr; 23(5):643-8. PubMed ID: 8678527
[TBL] [Abstract][Full Text] [Related]
9. Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival.
Korkolopoulou P; Kouzelis K; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
Acta Neuropathol; 1998 Jun; 95(6):617-24. PubMed ID: 9650754
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K
Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247
[TBL] [Abstract][Full Text] [Related]
11. Ham56-immunoreactive macrophages in untreated infiltrating gliomas.
Cummings TJ; Hulette CM; Bigner SH; Riggins GJ; McLendon RE
Arch Pathol Lab Med; 2001 May; 125(5):637-41. PubMed ID: 11300934
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
Prayson RA; Mohan DS; Song P; Suh JH
Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
[TBL] [Abstract][Full Text] [Related]
14. ACTC1 as an invasion and prognosis marker in glioma.
Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
[TBL] [Abstract][Full Text] [Related]
15. The significance of the expression of tumor suppressor gene DCC in human gliomas.
Nakatani K; Yoshimi N; Mori H; Sakai H; Shinoda J; Andoh T; Sakai N
J Neurooncol; 1998 Dec; 40(3):237-42. PubMed ID: 10066096
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of MIB-1 immunoreactivity, S-phase fraction, 5-bromo-2'-deoxyuridine labeling indices, and mitotic figures in gliomas.
Struikmans H; Rutgers DH; Jansen GH; Dullens HF; Oosten L; Tulleken CA; van der Tweel I; Battermann JJ
Radiat Oncol Investig; 1999; 7(4):243-8. PubMed ID: 10492165
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index.
Uematsu M; Ohsawa I; Aokage T; Nishimaki K; Matsumoto K; Takahashi H; Asoh S; Teramoto A; Ohta S
J Neurooncol; 2005 May; 72(3):231-8. PubMed ID: 15937645
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p53 immunoreactivity in patients with glioma.
Kyritsis AP; Bondy ML; Hess KR; Cunningham JE; Zhu D; Amos CJ; Yung WK; Levin VA; Bruner JM
Clin Cancer Res; 1995 Dec; 1(12):1617-22. PubMed ID: 9815964
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
[TBL] [Abstract][Full Text] [Related]
20. Radical surgery and reoperation in supratentorial malignant glial tumors.
Daneyemez M; Gezen F; Canakçi Z; Kahraman S
Minim Invasive Neurosurg; 1998 Dec; 41(4):209-13. PubMed ID: 9932265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
